Essure contraceptive: UK women to take legal action due to pain

Two hundred women in the United Kingdom can now take group legal action against the Essure contraceptive device, the women’s lawyers say.

The UK women complained of experiencing pain after having a permanent contraception device fitted into the fallopian tubes. The Essure coil, a device for female sterilization placed into each fallopian tube induces fibrosis and blockage, reportedly caused irreparable damage physically and mentally to women, as reported by the women’s lawyers.

Lawyers in the UK to take action

Lawyers in the UK now have permission to bring a group claim against the manufacturer on behalf of 200 women who experienced severe pain because of the device. 

Bayer, a German multinational pharmaceutical and biotechnology company, made the Essure birth-control device. The company said that it would defend itself vigorously against the claims.

Keep Reading

The Essure device was withdrawn from sale in 2017. However, the United Kingdom regulator said there was no risk to safety. The device caused immense pain to women.

Lawyers started legal action against the manufacturer in 2020.

Claims by women

Women complained of experiencing constant pain and complications, including heavy bleeding, after the procedure. They had to remove the device because of the pain. Some women said that the device, which is implanted in women’s fallopian tubes to permanently block the passage of eggs to the uterus, can be dangerous for them. They said that the device’s metal parts can cause damage to other parts of the body.

Deborah Chalk, 39, told BBC, “I began to suffer with headaches, abdominal pain, heavy bleeding, rashes, extreme itching and mood changes.”

Lisa Lunt, who represents the 200 women in the UK and is head of medical-product claims at law firm Pogust Goodhead, said that the device has adverse effects on women. She urged the company to compensate women. 

In 2020, the company paid around $1.6 billion to settle the majority of claims by women in the United States related to its Essure birth control device. However, the company has never admitted any wrongdoing.

About Senior Reporter

With over more than 6 years of writing obituaries for the local paper, Senior Reporter has a uniquely strong voice that shines through in his newest collection of essays and articles, which explores the importance we place on the legacy.

Senior Reporter

With over more than 6 years of writing obituaries for the local paper, Senior Reporter has a uniquely strong voice that shines through in his newest collection of essays and articles, which explores the importance we place on the legacy.

Recent Posts

Migrant Workers Returning from UAE With Kidney Failure Due to Extreme Temperatures

Over the last few years, newspapers have reported that migrant workers in the UAE and other Gulf countries have come…

December 4, 2025

Philippines OFWs in Israel: Relocation & Trauma Support After 2025 Border Tensions

Overseas Filipino Workers (OFWs) in Israel have once again found themselves on the frontlines of conflict, caught between their livelihoods…

December 4, 2025

Tea Garden Workers Get Land Rights — How Land Ownership Could Change Labour Justice in Rural India

Decades after decades, tea garden laborers in India have worked and lived in the farms without owning the land the…

December 4, 2025

U.S. Executive Order Against the Muslim Brotherhood Framed as a Global Security Imperative

There has also been a concerted global push on the side of the recent U.S. Executive Order against the Muslim…

December 4, 2025

Why the UN Migration Committee’s 2025 Recommendations Could Transform Migrant-Worker Rights Worldwide

The 2025 recommendations of the UN Migration Committee represent a change in the way governments are being encouraged to treat…

December 4, 2025

From Brick Kilns to Tech Startups: India’s Contract Workers Need Fair Legal Protection

The economic growth of India has been supported by a labor force that is rather silent and unguarded. Millions of…

December 3, 2025

This website uses cookies.

Read More